JOURNAL REVIEW

Authors and experts summarize and discuss newly published research in the peer-reviewed literature

Journal Review: Valerie Callender

February 7, 2022

Valerie Callender, MD, is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center, and is known for her sensitive and cutting-edge approach to the management of hair loss in women. Here, Dr. Callender discusses the article, “A Prospective Six-month Single-blind Study Evaluating Changes in Hair Growth and Quality Using a Nutraceutical Supplement in Men and Women of Diverse Ethnicities,” which was published in the January 2022 issue of the Journal of Clinical and Aesthetic Dermatology.

21-26_Raymond (2)Download

MORE JOURNAL REVIEWS

Emmy Graber, MD, MBA: Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne

Dr. Graber discusses her article published in JCAD January 2025, titled “Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne.” Reference:

...

Naiem T. Issa, MD, PhD: Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series

Dr. Naiem Issa discusses his article published in JCAD January 2025, titled “Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series.” Reference:

...

Nada Elbuluk, MD, MSc: Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study

Dr. Nada Elbuluk discusses her article published in JCAD January 2025, titled “Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study.” Reference:

...

Tina Bhutani, MD: Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis

Tina Bhutani, MD, discusses a new article published in the October 2024 issue of JCAD that describes patient-reported symptoms and treatment satisfaction in patients with moderate-to-severe plaque psoriasis treated with tildrakizumab 100mg over 64 weeks. Read full article here Reference:

...

Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact

Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic arthritis symptom onset and diagnosis to the likelihood and severity of depression, social impairment, and disease impact on quality of life. Read full article here Reference:

...

James Del Rosso, DO: Clindamycin— A Comprehensive Status Report with Emphasis on Use in Dermatology

James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive Status Report with Emphasis on Use in Dermatology.” Reference: Del Rosso J, Armillei MK, Lomakin IB, Grada A, Bunick CG. Clindamycin: A Comprehensive Status Report with Emphasis on Use in […]

...

Journal Review: Andrew Blauvelt

Andrew Blauvelt, MD, MBA, a dermatologist at the Oregon Medical Research Center in Portland, Oregon, discusses the impact Ruxolitinib cream has on itch in patients with atopic dermatitis which has been a predominant issue in disease symptoms....

Journal Review: Linda Stein Gold

Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, "Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy."...

Journal Review: Nanette Silverberg (Full Manuscript)

Nanette Silverberg, MD, a Clinical Professor of Pediatrics and Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, provides an overview of an article published in the Journal of Drugs in Dermatology regarding the use of a 308 nm laser for the treatment of pediatric vitiligo....